Author

S. M. Pitson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Assay:flow cytometry· 2 Organism:human· 2 Assay:imaging· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

L. M. Ebert· 2 shared M. N. Tea· 2 shared M. P. Brown· 2 shared M. R. Pitman· 2 shared R. Polara· 2 shared T. Gargett· 2 shared W. Yu· 2 shared A. Antebi· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

L. M. Ebert

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Mitochondrial translocation of TFEB regulates complex I and inflammation

C. Calabrese, H. Nolte, M. R. Pitman, R. Ganesan, P. Lampe, R. Laboy, R. Ripa, J. Fischer, S. Chipurupalli, S. Gutierrez, R. Polara, D. Thomas, S. M. Pitson, A. Antebi, N. Robinson

This study shows TFEB regulates mitochondrial complex I and inflammation through non-transcriptional mechanisms, with implications for immune pathogenesis during infection.

bioRxiv · Feb 27, 2023Cell Biology

Endogenous bystander killing mechanisms enhance the activity of novel FAP-CAR-T cells against glioblastoma

W. Yu, N. T. Truong, R. Polara, T. Gargett, M. N. Tea, S. M. Pitson, L. M. Ebert, M. P. Brown

This study shows FAP-CAR-T cells effectively kill glioblastoma cells through bystander mechanisms, even when only some cells express FAP, and demonstrate therapeutic efficacy in vivo.

bioRxiv · Feb 21, 2023 · PreprintImmunology

GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma

T. Gargett, L. M. Ebert, N. T. H. Truong, P. M. Kollis, K. Sedivakova, W. Yu, E. C. F. Yeo, N. L. Wittwer, B. L. Gliddon, M. N. Tea, R. Ormsby, J. Nowicki, S. Poonnoose, O. Vittorio, D. S. Ziegler, , M. P. Brown

This study demonstrates that GD2-targeting CAR-T cells, enhanced with IL-15 transgene expression, effectively control glioblastoma growth in a preclinical model and are clinically feasible.

bioRxiv · May 1, 2022Immunology

Slit-Robo Signalling Establishes a Sphingosine-1-Phosphate Gradient to Polarise Fin Mesenchyme and Establish Fin Morphology

H. Mahabaleshwar, A. P.V., T. Y. J. Loo, S. Y. Koh, M. R. Pitman, S. Kwok, J. Ma, B. Hu, F. Lin, X. L. Lok, S. M. Pitson, T. E. Saunders, T. J. Carney

The paper shows that Slit-Robo signaling coordinates with S1P to polarize fin mesenchyme and establish fin morphology in zebrafish.

bioRxiv · Dec 7, 2021 · PreprintCell Biology